Skip to content

Change in AR at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$44.01M-108%
Viatris logo
ViatrisVTRS
$126.3M+175%
ALN
Alnylam PharmaceuticalsALNY
$110.42M+1,385%
Amgen logo
AmgenAMGN
-$413M-132%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$19M-90.0%
Organon logo
OrganonOGN
$65M-23.5%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's change in AR?
ANI Pharmaceuticals (ANIP) reported change in AR of -$25.53M in Q1 2026.
How has ANI Pharmaceuticals's change in AR changed year-over-year?
ANI Pharmaceuticals's change in AR decreased by 1332.5% year-over-year, from -$1.78M to -$25.53M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.